The association between non-alcoholic fatty liver disease and carotid atherosclerosis in subjects with within-reference range alanine aminotransferase levels

Endocrine Journal

Volumn 60, Issue 12, 2013, Pages 1295-1301

  Kim, Kyung Soo ^a   Oh, Hyun Ju ^b   Kim, Dae Jung ^c   Kim, Soo Kyung ^a   Park, Seok Won ^a   Cho, Yong Wook ^a   Huh, Kap Bum ^d  

^a CHA University   (South Korea)

^b Korea Medical Institute   (South Korea)

^c Ajou University School of Medicine   (South Korea)

^d Huh's Diabetes Center   (South Korea)

Author keywords

Alanine aminotransferase; Intima media thickness; Non alcoholic fatty liver disease

Indexed keywords

ALANINE AMINOTRANSFERASE;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALCOHOL CONSUMPTION; ARTERIAL WALL THICKNESS; ARTICLE; CAROTID ATHEROSCLEROSIS; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; ECHOGRAPHY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NONALCOHOLIC FATTY LIVER; PREVALENCE; RISK FACTOR; SEX DIFFERENCE;

ADULT; ALANINE TRANSAMINASE; BIOLOGICAL MARKERS; CAROTID ARTERIES; CAROTID ARTERY DISEASES; CAROTID INTIMA-MEDIA THICKNESS; CROSS-SECTIONAL STUDIES; EARLY DIAGNOSIS; FATTY LIVER; FEMALE; HUMANS; LIVER; MALE; MASS SCREENING; MIDDLE AGED; PREVALENCE; REPUBLIC OF KOREA; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SEX CHARACTERISTICS;

EID: 84891402327     PISSN: 09188959     EISSN: 13484540     Source Type: Journal    
DOI: 10.1507/endocrj.EJ13-0269     Document Type: Article

References (32)

1. Angulo P (2002) Nonalcoholic fatty liver disease. N Engl J Med 346(16): 1221-1231.
2. Byrne CD, Olufadi R, Bruce KD, Cagampang FR, Ahmed MH (2009) Metabolic disturbances in non-alcoholic fatty liver disease. Clin Sci (Lond) 116(7): 539-564.
3. Luyckx FH, Lefebvre PJ, Scheen AJ (2000) Nonalcoholic steatohepatitis: association with obesity and insulin resistance, and influence of weight loss. Diabetes Metab 26(2): 98-106.
4. Marchesini G, Bugianesi E, Forlani G, Cerrelli F, Lenzi M, et al. (2003) Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology 37(4): 917-923.
5. Targher G, Bertolini L, Padovani R, Zenari L, Zoppini G, et al. (2004) Relation of nonalcoholic hepatic steatosis to early carotid atherosclerosis in healthy men: role of visceral fat accumulation. Diabetes Care 27(10): 2498-2500.
6. Adams LA, Angulo P (2005) Recent concepts in nonalcoholic fatty liver disease. Diabet Med 22(9): 1129-1133.
7. Choi HY, Hwang SY, Lee CH, Hong HC, Yang SJ, et al. (2013) Increased selenoprotein p levels in subjects with visceral obesity and nonalcoholic Fatty liver disease. Diabetes Metab J 37(1): 63-71.
8. Volzke H, Robinson DM, Kleine V, Deutscher R, Hoffmann W, et al. (2005) Hepatic steatosis is associated with an increased risk of carotid atherosclerosis. World J Gastroenterol 11(12): 1848-1853.
9. Sookoian S, Pirola CJ (2008) Non-alcoholic fatty liver disease is strongly associated with carotid atherosclerosis: a systematic review. J Hepatol 49(4): 600-607.
10. Aygun C, Kocaman O, Sahin T, Uraz S, Eminler AT, et al. (2008) Evaluation of metabolic syndrome frequency and carotid artery intima-media thickness as risk factors for atherosclerosis in patients with nonalcoholic fatty liver disease. Dig Dis Sci 53(5): 1352-1357.
11. Kim HC, Kim DJ, Huh KB (2009) Association between nonalcoholic fatty liver disease and carotid intima-media thickness according to the presence of metabolic syndrome. Atherosclerosis 204(2): 521-525.
12. Oh SY, Cho YK, Kang MS, Yoo TW, Park JH, et al. (2006) The association between increased alanine aminotransferase activity and metabolic factors in nonalcoholic fatty liver disease. Metabolism 55(12): 1604-1609.
13. Schindhelm RK, Dekker JM, Nijpels G, Bouter LM, Stehouwer CD, et al. (2007) Alanine aminotransferase predicts coronary heart disease events: a 10-year follow-up of the Hoorn Study. Atherosclerosis 191(2): 391-396.
14. Clark JM, Brancati FL, Diehl AM (2003) The prevalence and etiology of elevated aminotransferase levels in the United States. Am J Gastroenterol 98(5): 960-967.
15. Joy D, Thava VR, Scott BB (2003) Diagnosis of fatty liver disease: is biopsy necessary? Eur J Gastroenterol Hepatol 15(5): 539-543.
16. Ratziu V, Bellentani S, Cortez-Pinto H, Day C, Marchesini G (2010) A position statement on NAFLD/ NASH based on the EASL 2009 special conference. J Hepatol 53(2): 372-384.
17. Kong AP, Choi KC, Cockram CS, Ho CS, Chan MH, et al (2008) Independent associations of alanine aminotransferase (ALT) levels with cardiovascular risk factor clustering in Chinese adolescents. J Hepatol 49(1): 115-122.
18. Kim SK, Kim DJ, Kim SH, Lee YK, Park SW, et al. (2010) Normal range of alanine aminotransferase concentration is associated with carotid atherosclerosis. Diabetes Res Clin Pract 88(1): 111-116.
19. Steinvil A, Shapira I, Ben-Bassat OK, Cohen M, Vered Y, et al. (2010) The association of higher levels of within-normal-limits liver enzymes and the prevalence of the metabolic syndrome. Cardiovasc Diabetol 9: 30.
20. Arslan U, Türkoǧlu S, Balcioǧlu S, Tavil Y, Karakan T, et al. (2007) Association between nonalcoholic fatty liver disease and coronary artery disease. Coron Artery Dis 18(6): 433-436.
21. Sung KC, Ryan MC, Wilson AM (2009) The severity of nonalcoholic fatty liver disease is associated with increased cardiovascular risk in a large cohort of nonobese Asian subjects. Atherosclerosis 203(2): 581-586.
22. Kim D, Choi SY, Park EH, Lee W, Kang JH, et al. (2012) Nonalcoholic fatty liver disease is associated with coronary artery calcification. Hepatology 56(2): 605-613.
23. Huang Y, Bi Y, Xu M, Ma Z, Xu Y, et al. (2012) Nonalcoholic fatty liver disease is associated with atherosclerosis in middle-aged and elderly Chinese. Arterioscler Thromb Vasc Biol 32(9): 2321-2326.
24. Thakur ML, Sharma S, Kumar A, Bhatt SP, Luthra K, et al. (2012) Nonalcoholic fatty liver disease is associated with subclinical atherosclerosis independent of obesity and metabolic syndrome in Asian Indians. Atherosclerosis 223(2): 507-511.
25. Yun KE, Shin CY, Yoon YS, Park HS (2009) Elevated alanine aminotransferase levels predict mortality from cardiovascular disease and diabetes in Koreans. Atherosclerosis 205(2): 533-537.
26. Angulo P, Hui JM, Marchesini G, Bugianesi E, George J, et al. (2007) The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD. Hepatology 45(4): 846-854.
27. Chang Y, Ryu S, Sung E, Jang Y (2007) Higher concentrations of alanine aminotransferase within the reference interval predict nonalcoholic fatty liver disease. Clin Chem 53(4): 686-692.
28. Miyake T, Kumagi T, Hirooka M, Koizumi M, Furukawa S, et al. (2012) Metabolic markers and ALT cutoff level for diagnosing nonalcoholic fatty liver disease: a community-based cross-sectional study. J Gastroenterol 47(6): 696-703.
29. Patel DA, Srinivasan SR, Xu JH, Chen W, Berenson GS (2007) Persistent elevation of liver function enzymes within the reference range is associated with increased cardiovascular risk in young adults: the Bogalusa Heart Study. Metabolism 56(6): 792-798.
30. Shin HR (2006) Epidemiology of hepatitis C virus in Korea. Intervirology 49(1-2): 18-22.
31. Saadeh S, Younossi ZM, Remer EM, Gramlich T, Ong JP, et al. (2002) The utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterology 123(3): 745-750.
32. Fracanzani AL, Burdick L, Raselli S, Pedotti P, Grigore L, et al. (2008) Carotid artery intima-media thickness in nonalcoholic fatty liver disease. Am J Med 121(1): 72-78.